SHC
Income statement / Annual
Last year (2024), Sotera Health Company's total revenue was $1.10 B,
an increase of 4.88% from the previous year.
In 2024, Sotera Health Company's net income was $44.40 M.
See Sotera Health Company,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.10 B |
$1.05 B |
$1.00 B |
$931.48 M |
$818.16 M |
$778.33 M |
$746.15 M |
| Cost of Revenue |
$498.15 M
|
$472.13 M
|
$446.68 M
|
$412.81 M
|
$374.59 M
|
$382.90 M
|
$388.90 M
|
| Gross Profit |
$602.30 M
|
$577.16 M
|
$557.00 M
|
$518.67 M
|
$443.57 M
|
$395.43 M
|
$357.25 M
|
| Gross Profit Ratio |
0.55
|
0.55
|
0.55
|
0.56
|
0.54
|
0.51
|
0.48
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$133.36 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$242.63 M
|
$236.67 M
|
$245.71 M
|
$198.16 M
|
$178.53 M
|
$147.48 M
|
$133.36 M
|
| Other Expenses |
$62.04 M
|
$63.80 M
|
$62.94 M
|
$63.78 M
|
$59.03 M
|
$58.56 M
|
$3.87 M
|
| Operating Expenses |
$304.67 M
|
$300.47 M
|
$308.65 M
|
$261.94 M
|
$237.55 M
|
$206.04 M
|
$191.34 M
|
| Cost And Expenses |
$802.82 M
|
$772.60 M
|
$755.34 M
|
$674.75 M
|
$612.14 M
|
$588.94 M
|
$580.24 M
|
| Interest Income |
$0.00
|
$0.00
|
$80.14 M
|
$74.19 M
|
$215.26 M
|
$157.73 M
|
$0.00
|
| Interest Expense |
$164.69 M
|
$142.88 M
|
$80.14 M
|
$74.19 M
|
$215.26 M
|
$157.73 M
|
$143.33 M
|
| Depreciation & Amortization |
$163.64 M
|
$160.34 M
|
$147.75 M
|
$153.15 M
|
$145.51 M
|
$148.77 M
|
$148.15 M
|
| EBITDA |
$442.20 M |
$420.20 M |
-$2.99 M |
$404.25 M |
$319.96 M |
$305.25 M |
$316.60 M |
| EBITDA Ratio |
0.4
|
0.4
|
0.32
|
0.36
|
0.34
|
0.44
|
0.42
|
| Operating Income Ratio |
0.27
|
0.26
|
0.25
|
0.28
|
0.25
|
0.24
|
0.11
|
| Total Other Income/Expenses Net |
-$183.75 M
|
-$170.67 M
|
-$491.46 M
|
-$81.02 M
|
-$244.88 M
|
-$184.51 M
|
-$56.63 M
|
| Income Before Tax |
$113.87 M
|
$106.03 M
|
-$243.11 M
|
$175.72 M
|
-$38.86 M
|
-$916,000.00
|
$24.22 M
|
| Income Before Tax Ratio |
0.1
|
0.1
|
-0.24
|
0.19
|
-0.05
|
-0
|
0.03
|
| Income Tax Expense |
$69.48 M
|
$54.65 M
|
-$9.54 M
|
$58.60 M
|
-$1.37 M
|
$19.51 M
|
$30.10 M
|
| Net Income |
$44.40 M
|
$51.38 M
|
-$233.57 M
|
$116.88 M
|
-$37.49 M
|
-$20.43 M
|
-$5.87 M
|
| Net Income Ratio |
0.04
|
0.05
|
-0.23
|
0.13
|
-0.05
|
-0.03
|
-0.01
|
| EPS |
0.16 |
0.18 |
-0.83 |
0.41 |
-0.13 |
-0.0718 |
-0.0238 |
| EPS Diluted |
0.16 |
0.18 |
-0.83 |
0.41 |
-0.13 |
-0.0718 |
-0.0238 |
| Weighted Average Shares Out |
$282.78 M
|
$281.01 M
|
$280.10 M
|
$279.23 M
|
$283.25 M
|
$284.42 M
|
$246.15 M
|
| Weighted Average Shares Out Diluted |
$284.91 M
|
$283.22 M
|
$280.10 M
|
$279.38 M
|
$283.25 M
|
$284.42 M
|
$246.15 M
|
| Link |
|
|
|
|
|
|
|
